Cocaine : friend or foe ? IDAS, G; LADDU, A.International journal of clinical pharmacology, therapy and toxicology (1980). 1993, Vol 31, Num 9, pp 449-455, issn 0174-4879Article

EFFECTS OF ACEBUTOLOL AND PROPRANOLOL ON LEFT VENTRICULAR PERFORMANCE ASSESSED BY ECHOCARDIOGRAPHYCHANDRARATNA PAN; ARONOW WS; LADDU A et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 4; PP. 460-463; BIBL. 14 REF.Article

Cocaine : friend or foe ? IIDAS, G; LADDU, A.International journal of clinical pharmacology, therapy and toxicology (1980). 1993, Vol 31, Num 10, pp 489-496, issn 0174-4879Article

CIRCADIAN RHYTHM OF HOURLY VENTRICULAR ARRHYTHMIA FREQUENCY IN MANCANADA WB; WOODWARD W; LEE G et al.1983; ANGIOLOGY; ISSN 0003-3197; USA; DA. 1983; VOL. 34; NO 4; PP. 274-282; BIBL. 15 REF.Article

COMPARISON OF TWO METHODS OF ANALYZING FREQUENCY OF VENTRICULAR ARRHYTHMIASSHAPIRO W; CANADA WB; LEE G et al.1982; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1982; VOL. 104; NO 4; PART. 1; PP. 874-875; BIBL. 7 REF.Article

The efficacy and safety of terazosin for the treatment of symptomatic BPHLEPOR, H; HENRY, D; LADDU, A. R et al.The Prostate. 1991, Vol 18, Num 4, pp 345-355, issn 0270-4137, 11 p.Article

Analysis of adverse events in a dose titration studyPING-HWA HSU; LADDU, A. R.Journal of clinical pharmacology. 1994, Vol 34, Num 2, pp 136-141, issn 0091-2700Article

Therapeutic approach to unstable angina : nitroglycerin, heparin, and combined therapyJAFFRANI, N. A; EHRENPREIS, S; LADDU, A et al.The American heart journal. 1993, Vol 126, Num 5, pp 1239-1242, issn 0002-8703Article

A nineteen-year-old man with altered mental statusPIEPHO, R; WHELTON, A; MAYOR, G et al.Journal of clinical pharmacology. 1992, Vol 32, Num 6, pp 511-519, issn 0091-2700Article

Flestolol: an ultra-short-acting beta-adrenergic blocking agentBARTON, S. D; BURGE, J; PRASAD TURLAPATY et al.Journal of clinical pharmacology. 1986, Vol 26, pp A36-A39, issn 0091-2700, suppl. AArticle

Effect of age and dose on the incidence of adverse events in the treatment of hypertension in patients receiving terazosinHOSMANE, B. S; MAURATH, C. J; JORDAN, D. C et al.Journal of clinical pharmacology. 1992, Vol 32, Num 5, pp 434-443, issn 0091-2700Article

Terazosin : phramacokinetics and the effect of age and dose on the incidence of adverse eventsSOMBERG, J. C; ACHARI, R; LADDU, A. R et al.The American heart journal. 1991, Vol 122, Num 3, pp 901-905, issn 0002-8703, 2Conference Paper

Terazosin in the treatment of benign prostatic hyperplasia : the United States experienceLEPOR, H; LADDU, A.British journal of urology (Print). 1992, Vol 70, pp 2-9, issn 0007-1331, SUP1Conference Paper

Esmolol and the adrenergic response to perioperative stimuliSHRINIVAS MURTHY; TSAE-FUNG HWANG; SANDAGE, B. W et al.Journal of clinical pharmacology. 1986, Vol 26, pp A27-A35, issn 0091-2700, suppl. AArticle

Nicardipine in severe hypertension: oral therapy following intravenous treatmentWALLIN, J. D; BIENVENU, G. S; COOK, E et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1990, Vol 28, Num 1, pp 14-19, issn 0174-4879Article

Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmiasSTEINBERG, J. S; KATZ, R. J; SOMBERG, J. C et al.The American journal of cardiology. 1986, Vol 58, Num 10, pp 1005-1008, issn 0002-9149Article

Antiarrhythmic activity of esmolol (ASL-8052) ― a novel ultra-short acting beta-adrenoreceptor blocking agentKLEIN, G; WIRTZFELD, A; ALT, E et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 2, pp 112-117, issn 0174-4879Article

Combined terazosin and verapamil therapy in essential hypertension : hemodynamic and pharmacokinetic interactionsLENZ, M. L; POOL, J. L; LADDU, A. R et al.American journal of hypertension. 1995, Vol 8, Num 2, pp 133-145, issn 0895-7061Article

Acute hemodynamic effects of terazosin in hypertensive and normotensive patientsSTROM, J. A; ZOLA, B; FRISHMAN, W et al.The American heart journal. 1991, Vol 122, Num 3, pp 892-900, issn 0002-8703, 2Conference Paper

Effect of intracoronary nicardipine on methylergonovine-induced coronary artery spasm in patients with variant anginaBERTRAND, M. E; LA BLANCHE, J. M; HUDON, P et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1989, Vol 27, Num 1, pp 39-43, issn 0174-4879Article

Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoinGERBER, N; MAYS, D. C; DONN, K. H et al.Journal of clinical pharmacology. 1988, Vol 28, Num 11, pp 1023-1032, issn 0091-2700Article

Cardiovascular and neuromuscular effects of esmolol during induction of anesthesiaSHRINIVAS MURTHY, V; PATEL, K. D; ELANGOVAN, R. G et al.Journal of clinical pharmacology. 1986, Vol 26, Num 5, pp 351-357, issn 0091-2700Article

Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertensionBLACK, H. R; CHRYSANT, S. G; WOMBOLT, D. G et al.Journal of clinical pharmacology. 1992, Vol 32, Num 4, pp 351-359, issn 0091-2700Article